ProShare Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $855K | Sell |
13,536
-1,168
| -8% | -$73.8K | ﹤0.01% | 874 |
|
|
2025
Q1 | $779K | Sell |
14,704
-3,624
| -20% | -$192K | ﹤0.01% | 894 |
|
|
2024
Q4 | $1.03M | Buy |
18,328
+4,370
| +31% | +$245K | ﹤0.01% | 900 |
|
|
2024
Q3 | $731K | Buy |
13,958
+3,042
| +28% | +$159K | ﹤0.01% | 922 |
|
|
2024
Q2 | $448K | Sell |
10,916
-2,892
| -21% | -$119K | ﹤0.01% | 1039 |
|
|
2024
Q1 | $598K | Buy |
13,808
+1,527
| +12% | +$66.2K | ﹤0.01% | 982 |
|
|
2023
Q4 | $565K | Buy |
12,281
+1,886
| +18% | +$86.7K | ﹤0.01% | 970 |
|
|
2023
Q3 | $238K | Buy |
10,395
+34
| +0.3% | +$779 | ﹤0.01% | 1356 |
|
|
2023
Q2 | $171K | Buy |
+10,361
| New | +$171K | ﹤0.01% | 1573 |
|
|
2022
Q2 | – | Sell |
-13,465
| Closed | -$155K | – | 2070 |
|
|
2022
Q1 | $155K | Sell |
13,465
-3,242
| -19% | -$37.3K | ﹤0.01% | 1947 |
|
|
2021
Q4 | $168K | Buy |
16,707
+332
| +2% | +$3.34K | ﹤0.01% | 2089 |
|
|
2021
Q3 | $214K | Sell |
16,375
-4,075
| -20% | -$53.3K | ﹤0.01% | 1756 |
|
|
2021
Q2 | $400K | Buy |
20,450
+3,454
| +20% | +$67.6K | ﹤0.01% | 1696 |
|
|
2021
Q1 | $362K | Buy |
16,996
+2,727
| +19% | +$58.1K | ﹤0.01% | 1683 |
|
|
2020
Q4 | $424K | Buy |
14,269
+3,040
| +27% | +$90.3K | ﹤0.01% | 1375 |
|
|
2020
Q3 | $243K | Sell |
11,229
-383
| -3% | -$8.29K | ﹤0.01% | 1312 |
|
|
2020
Q2 | $259K | Buy |
+11,612
| New | +$259K | ﹤0.01% | 1308 |
|
|
2020
Q1 | – | Sell |
-13,472
| Closed | -$309K | – | 1506 |
|
|
2019
Q4 | $309K | Buy |
13,472
+1,514
| +13% | +$34.7K | ﹤0.01% | 1326 |
|
|
2019
Q3 | $258K | Buy |
11,958
+297
| +3% | +$6.41K | ﹤0.01% | 1305 |
|
|
2019
Q2 | $257K | Sell |
11,661
-1,682
| -13% | -$37.1K | ﹤0.01% | 1320 |
|
|
2019
Q1 | $366K | Buy |
13,343
+77
| +0.6% | +$2.11K | ﹤0.01% | 1160 |
|
|
2018
Q4 | $357K | Buy |
+13,266
| New | +$357K | ﹤0.01% | 1066 |
|